NEW YORK (GenomeWeb News) — Millipore yesterday said fourth-quarter revenues increased 50 percent as R&D spending rose 41 percent and profit leapt 1,700 percent.
 
Total receipts for the three months ended Dec. 31, 2006 increased to $383 million from $256 million year over year.
 
Compared with the fourth quarter of 2005, sales in the company’s Bioprocess segment was up 42 percent to $224 million, while its Bioscience segment gained 61 percent with sales of $158 million.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.